leisure time -WSS

leisure time

author：fashion 2025-09-27 12:55:44 - browse：733

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Does Paxlovid work in people vaccinated against Covid

WSS

Xenotransplantation trials will require adjusting expectations, experts say

Does Paxlovid work in people vaccinated against Covid

Merck to acquire Harpoon Therapeutics for $680 million

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Living organ donors deserve priority status for transplants

Altering the blood type of lungs raises potential for universal organs for transplants

entertainment

leisure time

entertainment

In age of alternative facts, a scholarly course on calling out crap

JPM pitch from hospitals? Revenue streams outside of patient care

Medical records are filled with copy

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

Psychedelics group wrestles with new pharma identity

Life science postdocs should get big pay hike, NIH panel says

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

How to save PrEP access — and even expand it

Eli Lilly’s Mounjaro succeeds in second weight

explore

A public health expert passes on football's full body collisions for youths

Male doctors called my cancer incurable. A female doctor showed it wasn't

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Millions may soon lose Medicaid when they don't have to

JPM pitch from hospitals? Revenue streams outside of patient care

focus

hotspot

knowledge

hotspot